MORRISVILLE, N.C., Aug. 9, 2018 /PRNewswire/ -- Alliance One
International, Inc. (NYSE: AOI) today announced that its indirect
subsidiary, FIGR Cannabis Inc., has taken a significant step
forward in its expansion plans as Goldleaf Pharm Inc., a subsidiary
of FIGR Cannabis, completed the purchase of a 20-acre property
adjacent to the Goldleaf facility in Simcoe, Ontario, Canada.
"Goldleaf Pharm is advancing through focused expansion in order
to meet the needs of Canadians as we prepare for the legalization
of recreational cannabis in Canada," said Larry
Huszczo, co-founder of Goldleaf Pharm Inc. "The additional
20-acres of land will give us more production space with the
ability to grow our current footprint to more than 700,000 square
feet."
"FIGR continues to innovate by focusing on brand and product
development," said Volker
Lauterbach, president of FIGR Cannabis. "Closing this deal
moves us toward our overall strategy and investment goal of
reaching one million square feet of production space for our
Ontario and Prince Edward Island locations. The Goldleaf
Pharm expansion will add well-located production space to support
capacity and product development."
Goldleaf Pharm Inc. is a late-stage applicant under Health
Canada's Access to Cannabis for Medical Purposes Regulations for
required licensing to produce and sell medicinal cannabis in
Ontario.
About Alliance One International, Inc.
Alliance One International (NYSE: AOI) is an agricultural
company that delivers value-added products and services to
businesses and customers, and is a trusted provider of responsibly
sourced, independently verified, sustainable and traceable products
and ingredients.
View original
content:http://www.prnewswire.com/news-releases/alliance-one-international-indirect-subsidiary-figr-cannabis-continues-production-expansion-300694643.html
SOURCE Alliance One International, Inc.